Orthobiologics are biologically derived treatments used to enhance healing of bone, cartilage, tendon, ligament and other musculoskeletal tissues. Common options include autologous bone graft, PRP, BMAC, bone graft substitutes, growth factors and cell-based therapies. PRP mainly provides platelet-derived signalling molecules, while BMAC is a heterogeneous marrow concentrate containing only a small proportion of mesenchymal stromal cells and should not be equated with purified stem-cell therapy. Stem-cell-based strategies may act through differentiation, paracrine signalling and immunomodulation, but their clinical effectiveness varies widely according to cell source, processing and indication. Orthobiologics should be used as an adjunct to sound mechanical principles and evidence-based patient selection, with careful distinction between symptomatic improvement and true tissue regeneration.
Which of the following best describes the primary purpose of Platelet-Rich Plasma (PRP) in orthobiologics?
A 45-year-old patient with a rotator cuff tear is considering treatment options. Which orthobiologic option is most commonly used to enhance healing in such cases?
What is the primary mechanism by which stem cells in orthobiologics exert their therapeutic effects?
Which statement about Bone Marrow Aspirate Concentrate (BMAC) is true?
A 60-year-old patient presents with a non-union fracture. Which orthobiologic option could be considered to enhance the healing process?
Which of the following growth factors is known for its role in bone healing?
In the context of orthobiologics, what is the significance of a scaffold?
What is the primary distinction between autologous and allogeneic grafts?
Which of the following is a potential downside of using allogeneic bone grafts?